Shandong Weigao Group Medical Polymer Company Limited

Sümbol: SHWGF

PNK

0.9575

USD

Turuhind täna

  • 15.4080

    P/E suhe

  • 0.0000

    PEG suhe

  • 4.33B

    MRK Cap

  • 0.02%

    DIV tootlus

Shandong Weigao Group Medical Polymer Company Limited (SHWGF) Finantsaruanded

Diagrammil näete Shandong Weigao Group Medical Polymer Company Limited (SHWGF) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Bilanss

Sukeldudes Shandong Weigao Group Medical Polymer Company Limited fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019

balance-sheet.row.cash-and-short-term-investments

01140.11157.21238.3
990.2
655.2

balance-sheet.row.short-term-investments

048.671.268.3
71.8
60.6

balance-sheet.row.net-receivables

01039.31016.6963.4
913.3
976.9

balance-sheet.row.inventory

0351.7332.8279.5
239
178.9

balance-sheet.row.other-current-assets

095.693.469.3
54.4
36.5

balance-sheet.row.total-current-assets

02626.726002550.5
2196.8
1811

balance-sheet.row.property-plant-equipment-net

0103410511055.1
932.6
798.8

balance-sheet.row.goodwill

0525.5523525.2
522.1
487.9

balance-sheet.row.intangible-assets

01507.3770.5807.4
836.4
813.4

balance-sheet.row.goodwill-and-intangible-assets

05235.11293.41332.6
1358.4
1301.3

balance-sheet.row.long-term-investments

0309.5316.4346.4
274.4
345.6

balance-sheet.row.tax-assets

029.222.924.6
21.4
14.5

balance-sheet.row.other-non-current-assets

0-4488.3-512.8-512.8
-508.6
-487.9

balance-sheet.row.total-non-current-assets

02119.521712245.9
2078.2
1972.2

balance-sheet.row.other-assets

0000
0
0

balance-sheet.row.total-assets

04746.247714796.4
4275
3783.2

balance-sheet.row.account-payables

0163.2207.3203.2
216.6
469.1

balance-sheet.row.short-term-debt

0449182.4150
99.1
152.9

balance-sheet.row.tax-payables

033.825.723.6
19.7
17.7

balance-sheet.row.long-term-debt-total

0210.8488.3542
610.5
636.7

Deferred Revenue Non Current

01.41.10.5
0.3
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-

balance-sheet.row.other-current-liab

0396.8410409.2
339.5
18.7

balance-sheet.row.total-non-current-liabilities

0286.9538.3668.5
674.3
679.3

balance-sheet.row.other-liabilities

0000
0
0

balance-sheet.row.capital-lease-obligations

014.2159.1
3.4
2.7

balance-sheet.row.total-liab

01355.71391.31480.7
1377.4
1337.3

balance-sheet.row.preferred-stock

0000
0
0

balance-sheet.row.common-stock

064.465.771.7
69.2
64.9

balance-sheet.row.retained-earnings

02625.82475.72381.5
2058.4
1707.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

087.6178.7160.6
236.2
180.8

balance-sheet.row.other-total-stockholders-equity

0386.7394.2430.3
393.8
369.7

balance-sheet.row.total-stockholders-equity

03164.53114.33044.1
2757.5
2322.9

balance-sheet.row.total-liabilities-and-stockholders-equity

04746.247714796.4
4275
3783.2

balance-sheet.row.minority-interest

0217.6255.5257.3
129.2
116.5

balance-sheet.row.total-equity

03382.13369.83301.4
2886.7
2439.4

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-

Total Investments

0358.1387.6414.7
346.2
406.1

balance-sheet.row.total-debt

0674685.6701.1
712.9
792.3

balance-sheet.row.net-debt

0-417.6-400.4-468.9
-205.4
137.1

Rahavoogude aruanne

Shandong Weigao Group Medical Polymer Company Limited finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM2022202120202019

cash-flows.row.net-income

0405.4351.7302.4
269.2

cash-flows.row.depreciation-and-amortization

0118.9113102.2
88.5

cash-flows.row.deferred-income-tax

0-469.7-381.9-294.9
0

cash-flows.row.stock-based-compensation

091.876.530.7
0

cash-flows.row.change-in-working-capital

0-158.8-38.1-30.3
-38.6

cash-flows.row.account-receivables

0-124.1-40.2-106.1
-100.7

cash-flows.row.inventory

0-80.2-27.9-37.9
-19

cash-flows.row.account-payables

064.1-11.284.1
75.4

cash-flows.row.other-working-capital

0-18.641.329.6
5.7

cash-flows.row.other-non-cash-items

0341337.5281.5
-13.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0

cash-flows.row.investments-in-property-plant-an-equipment

0-166.2-180.2-146
-143.4

cash-flows.row.acquisitions-net

04.9219.6-19.6
72.1

cash-flows.row.purchases-of-investments

0-247.2-5.9-27.6
-42.2

cash-flows.row.sales-maturities-of-investments

00.10.60.1
0

cash-flows.row.other-investing-activites

000.5216.9
0

cash-flows.row.net-cash-used-for-investing-activites

0-408.334.623.8
-113.5

cash-flows.row.debt-repayment

0-13.9-30.5-151.3
-2.8

cash-flows.row.common-stock-issued

0-35.240.437.5
0

cash-flows.row.common-stock-repurchased

0-5.2-11.3-1.9
-3.5

cash-flows.row.dividends-paid

0-110.4-101-101.6
-103.5

cash-flows.row.other-financing-activites

040.3-176.310.5
-1.6

cash-flows.row.net-cash-used-provided-by-financing-activities

0-124.5-278.7-206.9
-105.9

cash-flows.row.effect-of-forex-changes-on-cash

096.2-54.4-57
0

cash-flows.row.net-change-in-cash

0-84251.7263.1
67.6

cash-flows.row.cash-at-end-of-period

010861170918.3
655.2

cash-flows.row.cash-at-beginning-of-period

01170918.3655.2
587.7

cash-flows.row.operating-cash-flow

0328.6458.7391.6
305.7

cash-flows.row.capital-expenditure

0-166.2-180.2-146
-143.4

cash-flows.row.free-cash-flow

0162.4278.5245.6
162.3

Kasumiaruande rida

Shandong Weigao Group Medical Polymer Company Limited tulud muutusid võrreldes eelmise perioodiga NaN%. SHWGF brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019

income-statement-row.row.total-revenue

01871.62027.32041.4
1684.3
1511.1

income-statement-row.row.cost-of-revenue

0970.91005.8942.3
779.7
598.3

income-statement-row.row.gross-profit

0900.71021.61099.1
904.6
912.8

income-statement-row.row.gross-profit-ratio

0000
0
0

income-statement-row.row.research-development

0---
-
-

income-statement-row.row.selling-general-administrative

0---
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-

income-statement-row.row.other-expenses

06.610.310.9
10.3
8.4

income-statement-row.row.operating-expenses

0581.1566.3622.9
543.4
566.5

income-statement-row.row.cost-and-expenses

0155215721565.2
1323
1164.8

income-statement-row.row.interest-income

0235.726.822.4
16.7
18.8

income-statement-row.row.interest-expense

027328.521.7
25.9
57.9

income-statement-row.row.selling-and-marketing-expenses

0---
-
-

income-statement-row.row.total-other-income-expensenet

04.727.4-42.1
9.2
-30.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-

income-statement-row.row.other-operating-expenses

06.610.310.9
10.3
8.4

income-statement-row.row.total-operating-expenses

04.727.4-42.1
9.2
-30.3

income-statement-row.row.interest-expense

027328.521.7
25.9
57.9

income-statement-row.row.depreciation-and-amortization

0128.2118.9113
102.2
88.5

income-statement-row.row.ebitda-caps

0---
-
-

income-statement-row.row.operating-income

0319.6455.3476.1
361.3
346.3

income-statement-row.row.income-before-tax

0324.3482.7434
370.5
316

income-statement-row.row.income-tax-expense

043.563.264.9
51.9
47.6

income-statement-row.row.net-income

0283.2405.4351.7
302.4
269.2

Korduma kippuv küsimus

Mis on Shandong Weigao Group Medical Polymer Company Limited (SHWGF) koguvara?

Shandong Weigao Group Medical Polymer Company Limited (SHWGF) koguvara on 4746213417.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.482.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 0.075.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.152.

Mis on ettevõtte kogutulu?

Kogutulu on 0.168.

Mis on Shandong Weigao Group Medical Polymer Company Limited (SHWGF) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 283215434.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 674011810.000.

Mis on tegevuskulude arv?

Tegevuskulud on 581122121.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.